Literature DB >> 20219449

The concept of pharmacologic cocaine interception as a treatment for drug abuse.

Yang Gao1, Frank M Orson, Berma Kinsey, Tom Kosten, Stephen Brimijoin.   

Abstract

Cocaine access to brain tissue and associated cocaine-induced behaviors are substantially reduced in rats and mice by significant plasma levels of an enzyme that rapidly metabolizes the drug. Similar results have been obtained in rodents and humans with therapeutic anti-cocaine antibodies, which sequester the drug and prevent its entry into the brain. We show that an efficient cocaine hydrolase can lead to rapid unloading of anti-cocaine antibodies saturated with cocaine, and we provide a theoretical basis for the hypothesis that dual therapy with antibody and hydrolase enzyme may be especially effective. Copyright (c) 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20219449      PMCID: PMC2895017          DOI: 10.1016/j.cbi.2010.02.036

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  30 in total

1.  Gene transfer of cocaine hydrolase suppresses cardiovascular responses to cocaine in rats.

Authors:  Yang Gao; Elena Atanasova; Nan Sui; James D Pancook; Jeffry D Watkins; Stephen Brimijoin
Journal:  Mol Pharmacol       Date:  2004-10-01       Impact factor: 4.436

2.  Bioscavenger for protection from toxicity of organophosphorus compounds.

Authors:  Ashima Saxena; Wei Sun; Chunyuan Luo; Todd M Myers; Irwin Koplovitz; David E Lenz; Bhupendra P Doctor
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

Review 3.  Immunotherapy for the treatment of drug abuse.

Authors:  Thomas Kosten; S Michael Owens
Journal:  Pharmacol Ther       Date:  2005-10       Impact factor: 12.310

4.  Identification and characterization of single chain anti-cocaine catalytic antibodies.

Authors:  Kathleen M McKenzie; Jenny M Mee; Claude J Rogers; Mark S Hixon; Gunnar F Kaufmann; Kim D Janda
Journal:  J Mol Biol       Date:  2006-11-03       Impact factor: 5.469

Review 5.  Substance abuse vaccines.

Authors:  Frank M Orson; Berma M Kinsey; Rana A K Singh; Yan Wu; Tracie Gardner; Thomas R Kosten
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

6.  Repeated dosing with oral cocaine in humans: assessment of direct effects, withdrawal, and pharmacokinetics.

Authors:  Sharon L Walsh; William W Stoops; David E Moody; Shen-Nan Lin; George E Bigelow
Journal:  Exp Clin Psychopharmacol       Date:  2009-08       Impact factor: 3.157

7.  Lasting reduction of cocaine action in neostriatum--a hydrolase gene therapy approach.

Authors:  Yang Gao; Stephen Brimijoin
Journal:  J Pharmacol Exp Ther       Date:  2009-05-28       Impact factor: 4.030

8.  An albumin-butyrylcholinesterase for cocaine toxicity and addiction: catalytic and pharmacokinetic properties.

Authors:  Yang Gao; David LaFleur; Rutul Shah; Qinghai Zhao; Mallika Singh; Stephen Brimijoin
Journal:  Chem Biol Interact       Date:  2008-05-01       Impact factor: 5.192

9.  A cocaine hydrolase engineered from human butyrylcholinesterase selectively blocks cocaine toxicity and reinstatement of drug seeking in rats.

Authors:  Stephen Brimijoin; Yang Gao; Justin J Anker; Luke A Gliddon; David Lafleur; R Shah; Qinghai Zhao; M Singh; Marilyn E Carroll
Journal:  Neuropsychopharmacology       Date:  2008-01-16       Impact factor: 7.853

10.  Most efficient cocaine hydrolase designed by virtual screening of transition states.

Authors:  Fang Zheng; Wenchao Yang; Mei-Chuan Ko; Junjun Liu; Hoon Cho; Daquan Gao; Min Tong; Hsin-Hsiung Tai; James H Woods; Chang-Guo Zhan
Journal:  J Am Chem Soc       Date:  2008-08-19       Impact factor: 15.419

View more
  24 in total

Review 1.  Pharmacokinetic strategies for treatment of drug overdose and addiction.

Authors:  David A Gorelick
Journal:  Future Med Chem       Date:  2012-02       Impact factor: 3.808

Review 2.  Accelerating cocaine metabolism as an approach to the treatment of cocaine abuse and toxicity.

Authors:  Charles W Schindler; Steven R Goldberg
Journal:  Future Med Chem       Date:  2012-02       Impact factor: 3.808

Review 3.  Cocaine hydrolase gene therapy for cocaine abuse.

Authors:  Stephen Brimijoin; Yang Gao
Journal:  Future Med Chem       Date:  2012-02       Impact factor: 3.808

4.  Long-term reduction of cocaine self-administration in rats treated with adenoviral vector-delivered cocaine hydrolase: evidence for enzymatic activity.

Authors:  Natalie E Zlebnik; Stephen Brimijoin; Yang Gao; Amy T Saykao; Robin J Parks; Marilyn E Carroll
Journal:  Neuropsychopharmacology       Date:  2014-01-10       Impact factor: 7.853

5.  Reward and Toxicity of Cocaine Metabolites Generated by Cocaine Hydrolase.

Authors:  Vishakantha Murthy; Liyi Geng; Yang Gao; Bin Zhang; Jordan D Miller; Santiago Reyes; Stephen Brimijoin
Journal:  Cell Mol Neurobiol       Date:  2015-03-27       Impact factor: 5.046

6.  Modification of pharmacokinetic and abuse-related effects of cocaine by human-derived cocaine hydrolase in monkeys.

Authors:  Charles W Schindler; Zuzana Justinova; David Lafleur; Doug Woods; Viktor Roschke; Hussein Hallak; Liora Sklair-Tavron; Godfrey H Redhi; Sevil Yasar; Jack Bergman; Steven R Goldberg
Journal:  Addict Biol       Date:  2012-01-20       Impact factor: 4.280

Review 7.  Vaccines against drugs of abuse: where are we now?

Authors:  Berma Kinsey
Journal:  Ther Adv Vaccines       Date:  2014-07

Review 8.  Prospects, promise and problems on the road to effective vaccines and related therapies for substance abuse.

Authors:  Stephen Brimijoin; Xiaoyun Shen; Frank Orson; Thomas Kosten
Journal:  Expert Rev Vaccines       Date:  2013-03       Impact factor: 5.217

9.  Reaction Pathway and Free Energy Profile for Cocaine Hydrolase-Catalyzed Hydrolysis of (-)-Cocaine.

Authors:  Junjun Liu; Chang-Guo Zhan
Journal:  J Chem Theory Comput       Date:  2012-03-06       Impact factor: 6.006

10.  Plasma butyrylcholinesterase regulates ghrelin to control aggression.

Authors:  Vicky Ping Chen; Yang Gao; Liyi Geng; Robin J Parks; Yuan-Ping Pang; Stephen Brimijoin
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.